Fiscal year ending 2023. Filed on November 15, 2024.
20 Horseneck Lane 2nd Floor
Greenwich, Connecticut 06830
The Fibrolamellar Cancer Foundation (EIN: 27-0341021) has filed an IRS Form 990 since at least fiscal year 2016. In its fiscal year 2023 IRS Form 990 filing, The Fibrolamellar Cancer Foundation, a 501(c)(3) charitable organization, reported compensation for 3 out of 5 total employees. Among the employees shown here, the average compensation is $179,612. The highest compensated employee at The Fibrolamellar Cancer Foundation is Kurt Losert with fiscal year 2023 compensation of $279,981.
Revenue
Expenses
Employee compensation
FIBROLAMELLAR CANCER FOUNDATION,(THE "FOUNDATION") WAS ESTABLISHED TO RAISE AWARENESS AND RESEARCH FUNDS FOR FIBROLAMELLAR CARCINOMA, A RARE FORM OF LIVER CANCER THAT IS PRIMARILY SEEN IN TEENS AND YOUNG ADULTS. CURRENTLY, THERE ARE NO VIABLE TREATMENT OPTIONS OTHER THAN LIVER RESECTION SURGERY. OUR MISSION IS TO FIND A CURE AND RELIABLE TREATMENT OPTIONS FOR THOSE DIAGNOSED WITH THIS RARE DISEASE AS WELL AS ENHANCE COMMUNICATIONS AMONG HEALTHCARE PROFESSIONALS AND PATIENTS.
Be the first to know when new IRS Form 990 data is published for this organization.